LXLL.F logo

Eureka 93 OTCPK:LXLL.F Stock Report

Last Price

US$0.000001

Market Cap

US$74.0

7D

0%

1Y

n/a

Updated

27 Mar, 2024

Data

Company Financials

LXLL.F Stock Overview

Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada.

LXLL.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Eureka 93 Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Eureka 93
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.0001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.00%
5 Year Changen/a
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

LXLL.FUS Personal ProductsUS Market
7D0%-0.8%0.6%
1Yn/a-26.5%29.5%

Return vs Industry: Insufficient data to determine how LXLL.F performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how LXLL.F performed against the US Market.

Price Volatility

Is LXLL.F's price volatile compared to industry and market?
LXLL.F volatility
LXLL.F Average Weekly Movementn/a
Personal Products Industry Average Movement10.0%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: LXLL.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine LXLL.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aSeann Polihttps://www.eureka93.com

Eureka 93 Inc., a cannabidiol (CBD) life sciences company, engages in the research, development, extraction, production, processing, and distribution of CBD and other cannabinoids in the United States and Canada. The company offers hemp-derived CBD products, full plant extracts, and isolate powder. It is also involved in the development and manufacture of natural health products, as well as nutraceutical contract manufacturing business.

Eureka 93 Inc. Fundamentals Summary

How do Eureka 93's earnings and revenue compare to its market cap?
LXLL.F fundamental statistics
Market capUS$74.00
Earnings (TTM)-US$14.81m
Revenue (TTM)US$1.93m

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LXLL.F income statement (TTM)
RevenueUS$1.93m
Cost of Revenue-US$6.01m
Gross ProfitUS$7.94m
Other ExpensesUS$22.75m
Earnings-US$14.81m

Last Reported Earnings

Mar 31, 2019

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did LXLL.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.